High-Risk Indicators for Fontan Completion – #3 Other Factors

Even when cardiac anatomy and hemodynamics appear acceptable, patient-level factors outside the heart and lungs can substantially modify Fontan risk. Large registry and multicentre studies now show that genetic syndromes, baseline functional status, and chronic respiratory support needs are independently associated with higher mortality, greater resource use, and poorer long-term functional outcomes after single-ventricle palliation.[1–3] Johns Hopkins University+2PubMed+2

These considerations do not automatically preclude Fontan completion, but they should shift the discussion from “Can we do a Fontan?” to “Should we—and what are the realistic benefits and burdens for this child and family?”

1. Genetic & Syndromic Factors

Syndromic single-ventricle patients typically have multisystem disease, so the Fontan circulation must interact with extra-cardiac organ dysfunction, developmental delay, and heightened vulnerability to complications.

1.1 Trisomy 21 (Down syndrome)

The best data are for trisomy 21 (T21):

• In a Pediatric Cardiac Care Consortium cohort, 118 children with T21 and single-ventricle physiology underwent staged palliation. Among survivors of the initial operation, only 28% ultimately completed Fontan, and 10-year survival after Fontan discharge was 66.7% vs 92.2% in matched non-syndromic controls.[1] Johns Hopkins University
• A multicentre analysis of cavopulmonary connections showed that T21 was associated with a 5.5-fold increase in adjusted mortality, longer mechanical ventilation, and higher hospital costs compared with non-T21 patients.[2] PMC

These outcome gaps likely reflect several interacting vulnerabilities:

• Pulmonary vascular disease: T21 patients often have airway obstruction, sleep-disordered breathing, recurrent respiratory infections, and abnormal pulmonary vasoreactivity, predisposing to elevated PVR and reduced Fontan tolerance.
• Airway and respiratory issues: Macroglossia, midface hypoplasia, and hypotonia make airway management and postoperative respiratory care more challenging.
• Neurodevelopment and rehabilitation: Cognitive impairment and hypotonia may limit participation in early mobilisation and long-term exercise programmes that are essential to maintain Fontan performance.

1.2 Kabuki Syndrome

Kabuki syndrome is frequently associated with conotruncal and left-sided lesions, immune dysfunction, and craniofacial abnormalities. Hypotonia, joint laxity, and feeding difficulties can lead to:

• Delayed ambulation and reduced skeletal-muscle pumping of venous blood
• Poor nutritional reserve and vulnerability to catabolic stress
• Increased risk of postoperative respiratory complications

These factors may not preclude Fontan, but they narrow the physiologic and nutritional reserve available to tolerate Fontan-related venous hypertension.

1.3 Noonan Syndrome

In Noonan syndrome, the combination of pulmonary valve stenosis, hypertrophic cardiomyopathy, lymphatic abnormalities, and coagulation defects is particularly relevant:

• Lymphatic dysfunction amplifies the risk of chylothorax, chronic effusions, and protein-losing enteropathy—classic late Fontan complications.
• Coagulation abnormalities complicate anticoagulation in a circulation already prone to thrombosis.

1.4 Alagille Syndrome

Alagille syndrome blends cholestatic liver disease with peripheral pulmonary artery stenoses and other systemic features:

• Pre-existing cholestasis plus the intrinsic liver stress of Fontan physiology (chronic venous congestion, low cardiac output) may accelerate Fontan-associated liver disease.
• Branch PA hypoplasia/stenosis adds another load on the pulmonary vascular bed, making Fontan hemodynamics more precarious.

Clinical message:

The presence of any of these syndromes should trigger a broader, multidisciplinary assessment, including:

• Baseline liver function, coagulation profile, and nutritional status
• Detailed airway and respiratory evaluation
• Neurodevelopmental assessment and realistic appraisal of rehabilitation potential

Rather than focusing solely on anatomic “repairability,” the team must consider overall life expectancy, quality of life, and caregiver burden within each specific syndromic context.

2. Functional & Respiratory Status

Beyond diagnosis and anatomy, how the child functions in daily life is one of the strongest predictors of outcome. Longitudinal Fontan cohort data show that exercise capacity declines over time and is closely linked to health-related quality of life and risk of death or transplant.[3] PubMed+1

2.1 Non-ambulatory Status or Marked Difficulty with Ambulation

Children who are wheelchair-bound or minimally ambulatory often have underlying neuromuscular disease, cerebral palsy, severe developmental delay, or major orthopedic limitations. Consequences for Fontan physiology include:

• Reduced skeletal muscle pump activity, which normally augments venous return in a passive cavopulmonary circuit
• Higher risk of venous stasis, thrombosis, deconditioning, and pressure injuries
• Greater susceptibility to respiratory infections and prolonged ICU stays after major surgery

From a Fontan standpoint, non-ambulatory status does not absolutely prohibit completion, but it significantly narrows physiologic reserve and increases long-term care needs. In contrast, better functional capacity and higher peak VO₂ are associated with more favorable long-term outcomes in Fontan survivors.[3] UT Southwestern

2.2 History of Tracheostomy or Chronic NIPPV

A tracheostomy or long-term non-invasive positive pressure ventilation (NIPPV) usually indicates chronic lung disease, central hypoventilation, airway malacia, severe obstructive sleep apnea, or neuromuscular weakness. These conditions interact unfavorably with Fontan physiology:

• Positive pressure ventilation raises intrathoracic pressure, reducing venous return and Fontan flow.
• Higher PEEP increases pulmonary vascular resistance, further shrinking the transpulmonary gradient.
• Chronic tracheostomy is associated with airway colonisation and recurrent lower respiratory infections, compounding postoperative risk.

Thus, a history of tracheostomy or chronic NIPPV signals limited respiratory reserve and a higher likelihood of prolonged ventilation, extended ICU stays, and readmissions after Fontan.

3. Integrating “Other Factors” into the Fontan Risk Framework

When these “other factors” are incorporated into pre-Fontan decision-making, several principles emerge:

1. Syndrome ≠ Automatic Contraindication—but It Raises the Bar
• Many children with T21, Noonan, Kabuki, or Alagille syndromes can reach Glenn or Fontan with reasonable outcomes.[1,2] Johns Hopkins University+1
• However, their extra-cardiac vulnerabilities (pulmonary vascular disease, lymphatic dysfunction, liver disease, hypotonia) mean that smaller deviations from ideal Fontan physiology may have disproportionately large clinical consequences.
• The team should therefore require more robust hemodynamics and clearer anticipated benefit when considering Fontan completion.
2. Functional Status as a Surrogate for Global Reserve
• Ability to walk, participate in play, and perform age-appropriate activities reflects cardiopulmonary fitness, muscle mass, neurologic function, and motivation.
• In longitudinal Fontan studies, reduced exercise performance is strongly associated with worse functional health status and higher risk of death or transplant.[3] UT Southwestern
• Poor baseline function should therefore be weighted heavily when counselling families.
3. Respiratory Support as a Marker of Fontan Fragility
• Chronic tracheostomy or NIPPV indicates that the margin between compensated and decompensated respiratory status is already narrow.
• Superimposing Fontan physiology on this background may still be feasible, but it demands meticulous perioperative planning, realistic expectations, and often acceptance of long-term ventilatory support.
4. Shared Decision-Making and Alternative Pathways
• When several high-risk features cluster—e.g., syndromic diagnosis, non-ambulatory status, and ventilator dependence—the question may appropriately shift from “How do we optimise for Fontan?” to “Is Fontan the right goal?”
• For some children, continued Glenn palliation, an early transplant strategy, or a palliative-care–focused approach may better align with the anticipated trajectory and family priorities.

By explicitly considering genetic background, functional ability, and respiratory support needs alongside anatomy and hemodynamics, the heart team gains a more honest, holistic view of who truly stands to benefit from Fontan completion. These “other factors” do not simply add incremental risk; they reshape the entire risk–benefit equation and should be central to pre-Fontan conversations with families.

References

[1] Peterson JK, Setty SP, Knight JH, Thomas AS, Moller JH, Kochilas LK. Postoperative and long-term outcomes in children with Trisomy 21 and single ventricle palliation. Congenit Heart Dis. 2019;14(5):854-863. Johns Hopkins University

[2] Allen P, Anderson BR, Bacha E, LaPar DJ. Trisomy 21 patients undergoing cavopulmonary connections need improved preoperative and postoperative care. Ann Thorac Surg. 2021;112(6):2012-2019. PMC

[3] Atz AM, Zak V, Mahony L, et al. Longitudinal outcomes of patients with single ventricle after the Fontan procedure. J Am Coll Cardiol. 2017;69(22):2735-2744. UT Southwestern